Ovarian Cancer Trial, Recruiting (NCT05027828)

Ovarian Cancer Trial, Recruiting NCT05027828 Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine Condition: Ovarian Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT05027828 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Ovarian Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been recently diagnosed with ovarian cancer for the first time and have started treatment
Your cancer has been confirmed by a tissue sample (biopsy) to be a type that starts in the cells lining the ovaries, fallopian tubes, or the lining of the abdomen (called epithelial cancer)
Your cancer is at stage II, III, or IV, and doctors have determined that surgery is an option for you
You are 18 years of age or older
You and your family fully understand the study plan and are willing to sign a consent form agreeing to take part

Who may not be able to join:

Your ovarian cancer has been confirmed to be a type other than epithelial (for example, germ cell or stromal tumors)
Doctors have determined that surgery is not a suitable option for you
You have been diagnosed with another type of cancer in the last five years, or have another cancer at the time of joining the trial
You are not willing to use the standard first-line targeted medications used in this trial
You have a serious mental health condition
You have serious heart or blood vessel disease, an infection that cannot be controlled, or other serious ongoing health conditions that cannot be managed

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 2 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05027828

Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Phase: Not Applicable

Status: Recruiting

Condition: Ovarian Cancer

More information: https://clinicaltrials.gov/study/NCT05027828

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been recently diagnosed with ovarian cancer for the first time and have started treatment
Your cancer has been confirmed by a tissue sample (biopsy) to be a type that starts in the cells lining the ovaries, fallopian tubes, or the lining of the abdomen (called epithelial cancer)
Your cancer is at stage II, III, or IV, and doctors have determined that surgery is an option for you
You are 18 years of age or older
You and your family fully understand the study plan and are willing to sign a consent form agreeing to take part

Who may not be able to join:

Your ovarian cancer has been confirmed to be a type other than epithelial (for example, germ cell or stromal tumors)
Doctors have determined that surgery is not a suitable option for you
You have been diagnosed with another type of cancer in the last five years, or have another cancer at the time of joining the trial
You are not willing to use the standard first-line targeted medications used in this trial
You have a serious mental health condition
You have serious heart or blood vessel disease, an infection that cannot be controlled, or other serious ongoing health conditions that cannot be managed

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 2 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Registry

ClinicalTrials.gov

Start date

1 September 2021

Est. completion

30 April 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Progression-free survival

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov